Gland Pharma Ltd - Share Price Target 2026
(NSE: GLAND)
Sector: Healthcare
Market Cap: 3065705.14 Lakh Cr
2007.00
-2340.00
Target Price Range
1742.50
+23.30 (1.34%)
CMP
Bullish
As on 14 Jan 2026, 01:21 pm
Market Trends
Based on 2 research reports and 6 technical indicators.
Bullish5
Bearish1
Neutral2
Agg. Profit Potential26.36%
Agg. Risk 0.00%
Last updated on: 14/01/2026, 1:21 pm
Returns
| Period | Return % |
|---|---|
| 1 Month | -10.17 |
| 3 Months | 7.11 |
| 1 Year | -7.73 |
| 5 Years | -- |
Last updated on: 06/09/2025, 9:30 AM
Institutional Holdings
| Institute | Percentage | No. of Shares |
|---|---|---|
| Hdfc Mutual Fund - Hdfc Mid-Cap Fund | 6.34% | 10,439,701 |
| Mirae Asset Large & Midcap Fund | 6.05% | 9,966,465 |
| Nippon Life India Trustee Ltd- A/C Nippon India Growth Mid Cap Fund | 5.74% | 9,459,981 |
| Sbi Large & Midcap Fund | 3.16% | 5,212,034 |
| Icici Prudential India Opportunities Fund | 2.79% | 4,603,659 |
| Government Pension Fund Global | 1.34% | 2,213,039 |
| Uti-Flexi Cap Fund | 1.21% | 1,990,302 |
Last updated on: 9/30/2025, 12:00:00 AM
Loading technical analysis...
Fundamental Data
Fundamental Analysis
P/E Ratio
26.51
P/B Ratio
3.05
PEG Ratio
5.45
ROE
11.62%
EPS
70.19
Dividend Yield
0.97%
Market Cap
3065705.14 Lakh Cr
Sector
N/A
Last Updated: 10 Nov 2025, 01:30 pm
Peer Comparison
| Company | Sentiment | Target Price | Upside |
|---|---|---|---|
About : Gland Pharma Ltd.
Incorporated Year
1978
City and State
Hyderabad, Telangana
Listing Date
Director's Name
Allen Zhang
Revenue
41161.49 Cr
Net Profit
14655.85 Cr